Understanding what to ask after MASLD diagnosis
Tony Villiotti, who lives in Pennsylvania, was diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) in 2005, which progressed to metabolic-associated steatohepatitis by 2014. He reflects on the questions he wishes he’d asked earlier about MASLD progression.
Transcript
Two questions, really.
One, you know, “What’s next? What happens if this disease gets worse?” You know, “What lies ahead down the road for me if I ignore it or don’t take any precautions?”
The second question would be, “What can I do to either stop the progression of the disease or to reverse the disease?”
MASLD is a reversible disease. If you take the proper steps — lose weight, increase exercise, and so forth. So what the patient ought to be asking are the questions that would help them fight or reverse the disease.
Recent Posts
- Monitoring our son’s nutrition can be extra challenging during travel
- New Helix dataset aims to accelerate liver disease research
- Livmarli eases Alagille teen’s itch following liver transplant issues
- US enrollment starts for hepatitis B gene therapy clinical trial
- Women with PBC may be at high risk of disease flares after childbirth